Palmitoyl Pentapeptide-4 Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Palmitoyl Pentapeptide-4 dosing: protocols, safety, and where to buy.
Half-Life
No published human value. The relevant measurements are stability in skin rather than plasma. In hairless mouse skin extracts and homogenates both KTTKS and pal-KTTKS were degraded rapidly, with pal-KTTKS the more stable of the two, and adding protease inhibitors improved the stability of both (PMID: 25143811). In rat skin homogenate the free peptide was described as very susceptible to peptide bond cleavage by aminopeptidases present in the skin (PMID: 22921149).
Administration Routes
Dosage Calculator
Calculate exact dosing for Palmitoyl Pentapeptide-4.
Dosing data for Palmitoyl Pentapeptide-4 is being researched. Check the compound page for the latest information.
Side Effects & Safety
Contraindications
There is no drug labelling for palmitoyl pentapeptide-4, so there is no contraindication list. The cautions that follow from the published work are narrow. One human trial recorded a suspected allergic reaction and more frequent itching in the arm receiving a three-active cream that contained Matrixyl, in patients whose skin was already being irradiated (PMID: 15127162). Irradiated or broken skin is a setting where a cosmetic peptide cream has been tested once and did not help. The ingredient increases collagen and fibronectin production by design (PMID: 8486721), and the balance between helpful matrix synthesis and myofibroblast conversion shifted with concentration in culture (PMID: 30603464), which is a reason to treat scar-prone skin as an open question rather than an established use. Delivery is formulation-dependent: an analytical study of anti-wrinkle creams found that the formulation influenced how much pal-KTTKS was available in the product (PMID: 19393372), and in mouse skin the peptide reached the dermis only in small amounts (PMID: 25143811). Microneedling raised peptide signal in excised human skin by 2 to 22 fold (PMID: 25033398), so any device that breaks the barrier changes the exposure that the cosmetic trials tested. Nothing has been published on use in pregnancy, on children, or by any route other than topical.
Frequently Asked Questions
What is the recommended Palmitoyl Pentapeptide-4 dosage?
Dosage for Palmitoyl Pentapeptide-4 varies by protocol. Consult a qualified healthcare provider.
How often should I take Palmitoyl Pentapeptide-4?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Palmitoyl Pentapeptide-4 need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Palmitoyl Pentapeptide-4 side effects?
**What the trials recorded.** The 93-subject, 12-week, placebo-controlled split-face trial reported that pal-KTTKS at 3 parts per million was well tolerated by the skin, and the paper records no adverse effect beyond that statement (PMID: 18492182). The 21-subject 8-week trial in Indonesia set out partly because some anti-aging treatments irritate Asian skin more, and its abstract makes no statement about adverse events (PMID: 36909866). The two split-face studies of multi-ingredient products that contained the peptide make none either (PMID: 19735523). **One human trial with adverse events, in a multi-ingredient cream.** A randomized trial in 20 women having radiotherapy after breast-conserving surgery compared a cream whose stated actives were CM Glucan, Hydroxyprolisilan C and Matrixyl against a dexpanthenol lotion. It found no advantage for the test cream, and the adverse events that occurred were all in the test cream group: one suspected allergic reaction and two cases that required the radiotherapy planning simulation to be repeated, with mild itchiness and sporadic efflorescences seen more often (PMID: 15127162). The cream contained three actives, so nothing in that result can be assigned to the peptide alone. **Bioinformatic screening.** A 2026 safety framework paper from Procter and Gamble with Karl Lintner as a co-author ran palmitoyl pentapeptide-4 and six other peptides through six bioinformatic tools for toxin and allergen prediction. Palmitoyl pentapeptide-4 showed sequence homology with extracellular matrix proteins of skin, collagen, elastin and fibronectin, and did not raise the toxin or allergen flags that amanitin and conotoxin raised in the same run (PMID: 41953401). That is a computational screen written by people with a commercial interest in the ingredient, not a clinical safety study. **The mechanism-level caution.** The compound's job is to increase collagen production, and the one study that looked at the fibrotic side of that found a dose turning point: 0.1 micromolar reduced myofibroblast conversion in culture while 0.5 micromolar did not, and the authors wrote that the balance between wound healing and pro-fibrotic ability should guide dose selection (PMID: 30603464). No repeat-dose human safety study, no pregnancy data and no data on injected or oral use were found. Everything published is topical or in cell culture.
Where can I buy Palmitoyl Pentapeptide-4?
Visit our vendor directory to compare the vendors we track and their Trust Scores.
Free 2026 Peptide Cheat Sheet (PDF)
38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers.